GENEVA _ Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S.-based cancer drug partner.

Topics:  geneva    swiss   roche   genentech    u.s    billion   
BING NEWS:
  • Roche unit hits main goal in late-stage trial for flu therapy
    Roche (OTCQX:RHHBY) subsidiary Genentech announced on Thursday that Xofluza, an FDA-approved flu antiviral, achieved its primary goal in a global Phase 3 trial, indicating a reduction in influenza ...
    09/18/2024 - 11:51 pm | View Link
  • Positive Phase III Results Show Xofluza Significantly Reduces the Transmission of Influenza Viruses
    CENTERSTONE is the first global Phase III study to show a transmission reduction benefit with an antiviral used in the treatment of a respiratory viral illness. This new data may add to the benefits ...
    09/18/2024 - 6:06 pm | View Link
  • Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer
    Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), reported Peter Schmid, MD, PhD, of Barts Cancer Institute and Queen Mary ...
    09/17/2024 - 9:24 am | View Link
  • The essential biotech updates of the day
    AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — and it dramatically improved survival rates, according to new data.
    09/16/2024 - 2:15 am | View Link
  • Genentech, a biotech with a storied past, confronts new turbulence in the present
    For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...
    09/15/2024 - 9:30 pm | View Link
  • More
BING SEARCH:
  • Genentech: Press Releases | Friday, Sep 13, 2024
    Genentech and Roche are investigating more than a dozen medicines for neurological disorders, including multiple sclerosis, stroke, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, Duchenne muscular dystrophy and autism spectrum disorder. Together with our partners, we are committed to pushing the boundaries of scientific ...
    09/15/2024 - 5:16 am | View Website
  • Genentech: Press Releases | Thursday, Sep 12, 2024
    About Genentech. Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.
    09/14/2024 - 6:25 pm | View Website
  • Roche and Genentech Company Presentation
    Combining pharmaceuticals and diagnostics under one roof together with deep know-how in molecular biology and data science, makes Roche a unique partner to drive the next step in the evolution of healthcare. Leader in Pharma. Diagnosis Decision support Therapy Therapy monitoring.
    09/14/2024 - 8:59 am | View Website
  • About Us
    Genentech's South San Francisco campus serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development continues to embrace the spirit of a “startup” and operates as a separate business unit within Roche.
    09/13/2024 - 8:21 pm | View Website
  • Genentech
    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [5]
    09/13/2024 - 8:14 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News